Intervention

Riluzole

ClinicalTrials.gov intervention label

Clinical trials14
Recruiting2
Common conditions25
Lead sponsors shown11

Clinical trials

14 shown
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialNCT07447050 · 2025-12-23
RECRUITING
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialNCT06580002 · 2024-12-02
RECRUITING
The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant SchizophreniaNCT06270108 · 2022-11-14
UNKNOWN
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High InflammationNCT02796755 · 2016-04-01
COMPLETED
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialNCT01910259 · 2014-12-18
COMPLETED
Riluzole in Mild Alzheimer's DiseaseNCT01703117 · 2013-11-01
COMPLETED
Riluzole Augmentation Pilot in Depression (RAPID) TrialNCT01703039 · 2013-01-01
TERMINATED
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)NCT01709149 · 2012-10-01
COMPLETED
Efficacy and Tolerability of Riluzole in Treatment Resistant DepressionNCT01204918 · 2011-06-01
COMPLETED
Research Study for Major Depressive Disorder: Investigation of Glutamate MedicationsNCT00419003 · 2006-12-01
COMPLETED
Neuroprotection With Riluzole Patients With Early Multiple SclerosisNCT00501943 · 2006-07-01
COMPLETED
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar AtaxiaNCT00202397 · 2005-06-01
COMPLETED
Treatment of Refractory Schizophrenia With RiluzoleNCT00375050 · 2002-05-01
COMPLETED
Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)NCT00211224 · 2000-04-01
TERMINATED

Trial status mix

COMPLETED9
RECRUITING2
TERMINATED2
UNKNOWN1

Phase mix

PHASE29
PHASE42
EARLY_PHASE11
NA1
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.